High throughput detection of antibody self-interaction by bio-layer interferometry

mAbs

Volumn 5, Issue 6, 2013, Pages 838-841

  Sun, Tingwan ^a   Reid, Felicia ^a   Liu, Yuqi ^a   Cao, Yuan ^a   Estep, Patricia ^a   Nauman, Claire ^a   Xu, Yingda ^a  

^a Adimab LLC   (United States)

Author keywords

Aggregation; Bio layer interferometry; Developability; Monoclonal antibody; Self interaction; Solubility

Indexed keywords

ADALIMUMAB; CNTO 607; GOLD NANOPARTICLE; HUMAN MONOCLONAL ANTIBODY; IMMUNOGLOBULIN F(AB) FRAGMENT; IMMUNOGLOBULIN G ANTIBODY; IMMUNOGLOBULIN G1; IMMUNOGLOBULIN G1 ANTIBODY; MONOCLONAL ANTIBODY; POLYCLONAL ANTIBODY; UNCLASSIFIED DRUG; ANTIBODY;

ANTIBODY AND IMMUNOGLOBULIN STRUCTURE, FUNCTION AND PRODUCTION; ANTIBODY BLOOD LEVEL; ANTIBODY DETECTION; ANTIBODY SCREENING; ANTIBODY SELF INTERACTION; ANTIGEN BINDING; ARTICLE; BIOSENSOR; CELL STRAIN HEK293; CHROMATOGRAPHY; CLONE SELF INTERACTION BIO LAYER INTERFEROMETRY; HIGH THROUGHPUT SCREENING; HUMAN; INTERFEROMETRY; SOLUBILITY; VISCOSITY; METABOLISM;

ANTIBODIES; HIGH-THROUGHPUT SCREENING ASSAYS; INTERFEROMETRY;

EID: 84889816985     PISSN: 19420862     EISSN: 19420870     Source Type: Journal    
DOI: 10.4161/mabs.26186     Document Type: Article

References (29)

1. Zhang J, Liu XY. Effect of protein-protein interactions on protein aggregation kinetics. J Chem Phys 2003; 119:10972; http://dx.doi.org/10.1063/1. 1622380.
2. Yadav S, Liu J, Shire SJ, Kalonia DS. Specific interactions in high concentration antibody solutions resulting in high viscosity. J Pharm Sci 2010; 99:1152-68; http://dx.doi.org/10.1002/jps.21898; PMID:19705420
3. Kanai S, Liu J, Patapoff TW, Shire SJ. Reversible self-association of a concentrated monoclonal antibody solution mediated by Fab-Fab interaction that impacts solution viscosity. J Pharm Sci 2008; 97:4219-27; http://dx.doi.org/10. 1002/jps.21322; PMID:18240303
4. Saito S, Hasegawa J, Kobayashi N, Kishi N, Uchiyama S, Fukui K. Behavior of monoclonal antibodies: relation between the second virial coefficient (B (2)) at low concentrations and aggregation propensity and viscosity at high concentrations. Pharm Res 2012; 29:397-410; http://dx.doi.org/10.1007/s11095- 011-0563-x; PMID:21853361
5. Connolly BD, Petry C, Yadav S, Demeule B, Ciaccio N, Moore JM, Shire SJ, Gokarn YR. Weak interactions govern the viscosity of concentrated antibody solutions: high-throughput analysis using the diffusion interaction parameter. Biophys J 2012; 103:69-78; http://dx.doi.org/10.1016/j.bpj.2012.04.047; PMID:22828333
6. Patro SY, Przybycien TM. Self-interaction chromatography: a tool for the study of protein-protein interactions in bioprocessing environments. Biotechnol Bioeng 1996; 52:193-203; http://dx.doi.org/10.1002/(SICI)1097-0290(19961020)52: 2〈193::AID-BIT2〉3.0.CO;2-L; PMID:18629888
7. Tessier PM, Vandrey SD, Berger BW, Pazhianur R, Sandler SI, Lenhoff AM. Self-interaction chromatography: a novel screening method for rational protein crystallization. Acta Crystallogr D Biol Crystallogr 2002; 58:1531-5; PMID:12351855; http://dx.doi.org/10.1107/S0907444902012775
8. Tessier PM, Lenhoff AM, Sandler SI. Rapid measurement of protein osmotic second virial coefficients by self-interaction chromatography. Biophys J 2002; 82:1620-31; http://dx.doi.org/10.1016/S0006-3495(02)75513-6; PMID:11867474
9. García CD, Hadley DJ, Wilson WW, Henry CS. Measuring protein interactions by microchip self-interaction chromatography. Biotechnol Prog 2003; 19:1006-10; http://dx.doi.org/10.1021/bp025788z; PMID:12790668
10. Le Brun V, Friess W, Bassarab S, Mühlau S, Garidel P. A critical evaluation of self-interaction chromatography as a predictive tool for the assessment of protein-protein interactions in protein formulation development: a case study of a therapeutic monoclonal antibody. Eur J Pharm Biopharm 2010; 75:16-25; http://dx.doi.org/10.1016/j.ejpb.2010.01.009; PMID:20102739
11. Ahamed T, Ottens M, van Dedem GWK, van der Wielen LAM. Design of self-interaction chromatography as an analytical tool for predicting protein phase behavior. J Chromatogr A 2005; 1089:111-24; PMID:16130779; http://dx.doi.org/10.1016/j.chroma.2005.06.065
12. Johnson DH, Parupudi A, Wilson WW, DeLucas LJ. High-throughput self-interaction chromatography: applications in protein formulation prediction. Pharm Res 2009; 26:296-305; http://dx.doi.org/10.1007/s11095-008-9737-6; PMID:18923812
13. Ahamed T, Esteban BNA, Ottens M, van Dedem GW, van der Wielen LA, Bisschops MA, Lee A, Pham C, Thömmes J. Phase behavior of an intact monoclonal antibody. Biophys J 2007; 93:610-9; http://dx.doi.org/10.1529/ biophysj.106.098293; PMID:17449660
14. Jacobs SA, Wu S-J, Feng Y, Bethea D, O'Neil KT. Cross-interaction chromatography: a rapid method to identify highly soluble monoclonal antibody candidates. Pharm Res 2010; 27:65-71; http://dx.doi.org/10.1007/s11095-009-0007- z; PMID:19911257
15. Tessier PM, Sandler SI, Lenhoff AM. Direct measurement of protein osmotic second virial cross coefficients by cross-interaction chromatography. Protein Sci 2004; 13:1379-90; http://dx.doi.org/10.1110/ps.03419204; PMID:15075404
16. Spencer S, Bethea D, Raju TS, Giles-Komar J, Feng Y. Solubility evaluation of murine hybridoma antibodies. MAbs 2012; 4:319-25; PMID:22531448; http://dx.doi.org/10.4161/mabs.19869
17. Sule SV, Sukumar M, Weiss WF 4th, Marcelino-Cruz AM, Sample T, Tessier PM. High-throughput analysis of concentration-dependent antibody self-association. Biophys J 2011; 101:1749-57; http://dx.doi.org/10.1016/j.bpj. 2011.08.036; PMID:21961601
18. Sule SV, Dickinson CD, Lu J, Chow C-K, Tessier PM. Rapid analysis of antibody self-association in complex mixtures using immunogold conjugates. Mol Pharm 2013; 10:1322-31; http://dx.doi.org/10.1021/mp300524x; PMID:23383873
19. Nishi H, Miyajima M, Wakiyama N, Kubota K, Hasegawa J, Uchiyama S, Fukui K. Fc domain mediated self-association of an IgG1 monoclonal antibody under a low ionic strength condition. J Biosci Bioeng 2011; 112:326-32; http://dx.doi.org/10.1016/j.jbiosc.2011.06.017; PMID:21783411
20. Rich RL, Myszka DG. Higher-throughput, label-free, real-time molecular interaction analysis. Anal Biochem 2007; 361:1-6; http://dx.doi.org/10.1016/j. ab.2006.10.040; PMID:17145039
21. Abdiche YN, Malashock DS, Pinkerton A, Pons J. Exploring blocking assays using Octet, ProteOn, and Biacore biosensors. Anal Biochem 2009; 386:172-80; http://dx.doi.org/10.1016/j.ab.2008.11.038; PMID:19111520
22. Concepcion J, Witte K, Wartchow C, Choo S, Yao D, Persson H, Wei J, Li P, Heidecker B, Ma W, et al. Label-free detection of biomolecular interactions using BioLayer interferometry for kinetic characterization. Comb Chem High Throughput Screen 2009; 12:791-800; PMID:19758119; http://dx.doi.org/10.2174/ 138620709789104915
23. Wu S-J, Luo J, O'Neil KT, Kang J, Lacy ER, Canziani G, Baker A, Huang M, Tang QM, Raju TS, et al. Structure-based engineering of a monoclonal antibody for improved solubility. Protein Eng Des Sel 2010; 23:643-51; http://dx.doi.org/10.1093/protein/gzq037; PMID:20543007
24. Bethea D, Wu S-J, Luo J, Hyun L, Lacy ER, Teplyakov A, Jacobs SA, O'Neil KT, Gilliland GL, Feng Y. Mechanisms of self-association of a human monoclonal antibody CNTO607. Protein Eng Des Sel 2012; 25:531-7; http://dx.doi.org/10.1093/ protein/gzs047; PMID:22915597
25. Perchiacca JM, Tessier PM. Engineering aggregation-resistant antibodies. Annu Rev Chem Biomol Eng 2012; 3:263-86; http://dx.doi.org/10.1146/annurev- chembioeng-062011-081052; PMID:22468604
26. Dudgeon K, Rouet R, Kokmeijer I, Schofield P, Stolp J, Langley D, Stock D, Christ D. General strategy for the generation of human antibody variable domains with increased aggregation resistance. Proc Natl Acad Sci U S A 2012; 109:10879-84; http://dx.doi.org/10.1073/pnas.1202866109; PMID:22745168
27. Wang X, Singh SK, Kumar S. Potential aggregation-prone regions in complementarity-determining regions of antibodies and their contribution towards antigen recognition: a computational analysis. Pharm Res 2010; 27:1512-29; http://dx.doi.org/10.1007/s11095-010-0143-5; PMID:20422267
28. Pepinsky RB, Silvian L, Berkowitz SA, Farrington G, Lugovskoy A, Walus L, Eldredge J, Capili A, Mi S, Graff C, et al. Improving the solubility of anti-LINGO-1 monoclonal antibody Li33 by isotype switching and targeted mutagenesis. Protein Sci 2010; 19:954-66; PMID:20198683
29. Saluja A, Kalonia DS. Nature and consequences of protein-protein interactions in high protein concentration solutions. Int J Pharm 2008; 358:1-15; http://dx.doi.org/10.1016/j.ijpharm.2008.03.041; PMID:18485634